Refining systemic therapy for early breast cancer: difficulties with subtraction.

Hdl Handle:
http://hdl.handle.net/10147/207783
Title:
Refining systemic therapy for early breast cancer: difficulties with subtraction.
Authors:
Dodwell, David; Thorpe, Helen; Coleman, Robert
Affiliation:
St James's Institute of Oncology, St James Hospital, Beckett St, Leeds, UK., david.dodwell@leedsth.nhs.uk
Citation:
Lancet Oncol. 2009 Aug;10(8):738-9.
Journal:
The lancet oncology
Issue Date:
1-Feb-2012
URI:
http://hdl.handle.net/10147/207783
DOI:
10.1016/S1470-2045(09)70203-7
PubMed ID:
19647192
Language:
eng
MeSH:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use; Breast Neoplasms/*drug therapy/pathology; Clinical Trials as Topic; Female; Humans
ISSN:
1474-5488 (Electronic); 1470-2045 (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorDodwell, Daviden_GB
dc.contributor.authorThorpe, Helenen_GB
dc.contributor.authorColeman, Roberten_GB
dc.date.accessioned2012-02-01T10:44:35Z-
dc.date.available2012-02-01T10:44:35Z-
dc.date.issued2012-02-01T10:44:35Z-
dc.identifier.citationLancet Oncol. 2009 Aug;10(8):738-9.en_GB
dc.identifier.issn1474-5488 (Electronic)en_GB
dc.identifier.issn1470-2045 (Linking)en_GB
dc.identifier.pmid19647192en_GB
dc.identifier.doi10.1016/S1470-2045(09)70203-7en_GB
dc.identifier.urihttp://hdl.handle.net/10147/207783-
dc.language.isoengen_GB
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols/*therapeutic useen_GB
dc.subject.meshBreast Neoplasms/*drug therapy/pathologyen_GB
dc.subject.meshClinical Trials as Topicen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHumansen_GB
dc.titleRefining systemic therapy for early breast cancer: difficulties with subtraction.en_GB
dc.contributor.departmentSt James's Institute of Oncology, St James Hospital, Beckett St, Leeds, UK., david.dodwell@leedsth.nhs.uken_GB
dc.identifier.journalThe lancet oncologyen_GB
dc.description.provinceLeinster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.